BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26378795)

  • 1. Heterosexual Transmission of Subtype C HIV-1 Selects Consensus-Like Variants without Increased Replicative Capacity or Interferon-α Resistance.
    Deymier MJ; Ende Z; Fenton-May AE; Dilernia DA; Kilembe W; Allen SA; Borrow P; Hunter E
    PLoS Pathog; 2015 Sep; 11(9):e1005154. PubMed ID: 26378795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infection with multiple HIV-1 founder variants is associated with lower viral replicative capacity, faster CD4+ T cell decline and increased immune activation during acute infection.
    Macharia GN; Yue L; Staller E; Dilernia D; Wilkins D; Song H; McGowan E; King D; Fast P; Imami N; Price MA; Sanders EJ; Hunter E; Gilmour J
    PLoS Pathog; 2020 Sep; 16(9):e1008853. PubMed ID: 32886726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variants from the diverse virus population identified at seroconversion of a clade A human immunodeficiency virus type 1-infected woman have distinct biological properties.
    Poss M; Overbaugh J
    J Virol; 1999 Jul; 73(7):5255-64. PubMed ID: 10364271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to type 1 interferons is a major determinant of HIV-1 transmission fitness.
    Iyer SS; Bibollet-Ruche F; Sherrill-Mix S; Learn GH; Plenderleith L; Smith AG; Barbian HJ; Russell RM; Gondim MV; Bahari CY; Shaw CM; Li Y; Decker T; Haynes BF; Shaw GM; Sharp PM; Borrow P; Hahn BH
    Proc Natl Acad Sci U S A; 2017 Jan; 114(4):E590-E599. PubMed ID: 28069935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of HIV-1 envelopes in acutely and chronically infected injection drug users.
    Etemad B; Gonzalez OA; White L; Laeyendecker O; Kirk GD; Mehta S; Sagar M
    Retrovirology; 2014 Nov; 11():106. PubMed ID: 25430652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The apparent interferon resistance of transmitted HIV-1 is possibly a consequence of enhanced replicative fitness.
    Sugrue E; Wickenhagen A; Mollentze N; Aziz MA; Sreenu VB; Truxa S; Tong L; da Silva Filipe A; Robertson DL; Hughes J; Rihn SJ; Wilson SJ
    PLoS Pathog; 2022 Nov; 18(11):e1010973. PubMed ID: 36399512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deciphering Multiplicity of HIV-1C Infection: Transmission of Closely Related Multiple Viral Lineages.
    Novitsky V; Moyo S; Wang R; Gaseitsiwe S; Essex M
    PLoS One; 2016; 11(11):e0166746. PubMed ID: 27893822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fc-gamma receptor IIA and IIIA variants in two African cohorts: Lack of consistent impact on heterosexual HIV acquisition, viral control, and disease progression.
    Connolly S; Wall KM; Tang J; Yu T; Kilembe W; Kijak G; Allen S; Hunter E
    Virology; 2018 Dec; 525():132-142. PubMed ID: 30278383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomewide association study for determinants of HIV-1 acquisition and viral set point in HIV-1 serodiscordant couples with quantified virus exposure.
    Lingappa JR; Petrovski S; Kahle E; Fellay J; Shianna K; McElrath MJ; Thomas KK; Baeten JM; Celum C; Wald A; de Bruyn G; Mullins JI; Nakku-Joloba E; Farquhar C; Essex M; Donnell D; Kiarie J; Haynes B; Goldstein D;
    PLoS One; 2011; 6(12):e28632. PubMed ID: 22174851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization of HIV-1-Infected Persons With Autologous Dendritic Cells Transfected With mRNA Encoding HIV-1 Gag and Nef: Results of a Randomized, Placebo-Controlled Clinical Trial.
    Gandhi RT; Kwon DS; Macklin EA; Shopis JR; McLean AP; McBrine N; Flynn T; Peter L; Sbrolla A; Kaufmann DE; Porichis F; Walker BD; Bhardwaj N; Barouch DH; Kavanagh DG
    J Acquir Immune Defic Syndr; 2016 Mar; 71(3):246-53. PubMed ID: 26379068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation.
    Rosa A; Chande A; Ziglio S; De Sanctis V; Bertorelli R; Goh SL; McCauley SM; Nowosielska A; Antonarakis SE; Luban J; Santoni FA; Pizzato M
    Nature; 2015 Oct; 526(7572):212-7. PubMed ID: 26416734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent Simian Immunodeficiency Virus Infection Causes Ultimate Depletion of Follicular Th Cells in AIDS.
    Xu H; Wang X; Malam N; Lackner AA; Veazey RS
    J Immunol; 2015 Nov; 195(9):4351-7. PubMed ID: 26408660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adipose Tissue Is a Neglected Viral Reservoir and an Inflammatory Site during Chronic HIV and SIV Infection.
    Damouche A; Lazure T; Avettand-Fènoël V; Huot N; Dejucq-Rainsford N; Satie AP; Mélard A; David L; Gommet C; Ghosn J; Noel N; Pourcher G; Martinez V; Benoist S; Béréziat V; Cosma A; Favier B; Vaslin B; Rouzioux C; Capeau J; Müller-Trutwin M; Dereuddre-Bosquet N; Le Grand R; Lambotte O; Bourgeois C
    PLoS Pathog; 2015 Sep; 11(9):e1005153. PubMed ID: 26402858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation and lysis of human CD4 cells latently infected with HIV-1.
    Pegu A; Asokan M; Wu L; Wang K; Hataye J; Casazza JP; Guo X; Shi W; Georgiev I; Zhou T; Chen X; O'Dell S; Todd JP; Kwong PD; Rao SS; Yang ZY; Koup RA; Mascola JR; Nabel GJ
    Nat Commun; 2015 Oct; 6():8447. PubMed ID: 26485194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Assay to Measure the Magnitude of the Inducible Viral Reservoir in HIV-infected Individuals.
    Procopio FA; Fromentin R; Kulpa DA; Brehm JH; Bebin AG; Strain MC; Richman DD; O'Doherty U; Palmer S; Hecht FM; Hoh R; Barnard RJ; Miller MD; Hazuda DJ; Deeks SG; Sékaly RP; Chomont N
    EBioMedicine; 2015 Aug; 2(8):874-83. PubMed ID: 26425694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood-Derived CD4 T Cells Naturally Resist Pyroptosis during Abortive HIV-1 Infection.
    Muñoz-Arias I; Doitsh G; Yang Z; Sowinski S; Ruelas D; Greene WC
    Cell Host Microbe; 2015 Oct; 18(4):463-70. PubMed ID: 26468749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Member of the V1V2-Directed CAP256-VRC26 Lineage That Shows Increased Breadth and Exceptional Potency.
    Doria-Rose NA; Bhiman JN; Roark RS; Schramm CA; Gorman J; Chuang GY; Pancera M; Cale EM; Ernandes MJ; Louder MK; Asokan M; Bailer RT; Druz A; Fraschilla IR; Garrett NJ; Jarosinski M; Lynch RM; McKee K; O'Dell S; Pegu A; Schmidt SD; Staupe RP; Sutton MS; Wang K; Wibmer CK; Haynes BF; Abdool-Karim S; Shapiro L; Kwong PD; Moore PL; Morris L; Mascola JR
    J Virol; 2016 Jan; 90(1):76-91. PubMed ID: 26468542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral variants that initiate and drive maturation of V1V2-directed HIV-1 broadly neutralizing antibodies.
    Bhiman JN; Anthony C; Doria-Rose NA; Karimanzira O; Schramm CA; Khoza T; Kitchin D; Botha G; Gorman J; Garrett NJ; Abdool Karim SS; Shapiro L; Williamson C; Kwong PD; Mascola JR; Morris L; Moore PL
    Nat Med; 2015 Nov; 21(11):1332-6. PubMed ID: 26457756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-to-cell infection by HIV contributes over half of virus infection.
    Iwami S; Takeuchi JS; Nakaoka S; Mammano F; Clavel F; Inaba H; Kobayashi T; Misawa N; Aihara K; Koyanagi Y; Sato K
    Elife; 2015 Oct; 4():. PubMed ID: 26441404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo.
    Søgaard OS; Graversen ME; Leth S; Olesen R; Brinkmann CR; Nissen SK; Kjaer AS; Schleimann MH; Denton PW; Hey-Cunningham WJ; Koelsch KK; Pantaleo G; Krogsgaard K; Sommerfelt M; Fromentin R; Chomont N; Rasmussen TA; Østergaard L; Tolstrup M
    PLoS Pathog; 2015 Sep; 11(9):e1005142. PubMed ID: 26379282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.